Alejandro Martinez Estaban

Alejandro Martinez Estaban

Auto-generated profile, based on publicly available information

Alejandro Martinez Estaban

Department of Urology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de México, México

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
Javier Mancilla-GalindoJavier Mancilla-Galindo
Javier Mancilla-Galindo
Ashuin Kammar-GarcíaAshuin Kammar-García
Ashuin Kammar-García
AMA. Martínez-Esteban
A. Martínez-Esteban
HMHéctor David Meza-Comparán
Héctor David Meza-Comparán
JMJavier Mancilla-Ramirez
Javier Mancilla-Ramirez
NGNorma Galindo-Sevilla
Norma Galindo-Sevilla
We conducted a retrospective observational study in patients with laboratory-confirmed coronavirus disease (COVID-19) who received medical care in 688 COVID-19 ambulatory units and hospitals in Mexico City between 24 February 2020 and 24 December 2020, to study if the elderly seek medical care later than younger patients and their severity of symptoms at initial medical evaluation. Patients were categorised into eight groups (<20, 20–29, 30–39, 40–49, 50–59, 60–69, 70–79 and ≥80 years). Symptoms at initial evaluation were classified according to a previously validated classification into respiratory and non-respiratory symptoms. Comparisons between time from symptom onset to medical care for every age category were performed through variance analyses. Logistic regression models were applied to determine the risk of presenting symptoms of severity according to age, and mortality risk according to delays in medical care. In total, 286 020 patients were included (mean age: 42.8, s.d.: 16.8 years; 50.4% were women). Mean time from symptom onset to medical care was 4.04 (s.d.: 3.6) days and increased with older age categories (P < 0.0001). Mortality risk increased by 6.4% for each day of delay in medical care from symptom onset. The risk of presenting with the symptoms of severity was greater with increasing age categories. In conclusion, COVID-19 patients with increasing ages tend to seek medical care later, with higher rates of symptoms of severity at initial presentation in both ambulatory units and hospitals.

1 March 2022 in Journal of Endourology
Verified
Journal Article
Closed access
HMHector Manuel Orozco Murillo
Hector Manuel Orozco Murillo
BRBenjamín Montaño Roca
Benjamín Montaño Roca
ESElisa Kobashi Sandoval
Elisa Kobashi Sandoval
JPJesús Varela Prieto
Jesús Varela Prieto
RSRocío Estephanía Arzate Soriano
Rocío Estephanía Arzate Soriano
CMCarlos E. Mendez-Probst
Carlos E. Mendez-Probst
Purpose: The aim of this study is to conduct a prospective, controlled single-center study to determine the prevalence and types of ureteral stent symptoms in kidney transplant (KTx) recipients and compare them with nontransplant subjects. Materials and Methods: From December 2012 to June 2019, a total of 102 patients having undergone a KTx and Double-J stent (DJS) placement and 88 patients having undergone endourological lithotripsy and DJS placement were enrolled. The Ureteral Stent Symptom Questionnaire (USSQ) was administered to patients with a median of 25 (KTx) and 31 (urolithiasis) days after stent placement. USSQ scores were used to compare symptoms between the two groups. Results: Of the 190 patients enrolled, 88 belonged to the lithotripsy group (control group) and 102 to the KTx recipients' group. Mean score for urinary symptoms was 21.42 for KTx patients vs 27.53 for control patients with statistical significance ( p < 0.001, CI −7.792 to −4.433). The visual analog scale, overall bother, pain at voiding, flank pain at voiding, and frequency of painkiller use scores were significantly higher for control patients than for KTx patients ( p = 0.024, <0.001, <0.001, <0.001, and 0.014, respectively). Frequency of rest, changes in work duration, work domain score, suspicion of urinary tract infection (UTI), and need for professional assistance scores were significantly lower for KTx patients than the control. There were no significant differences in general health and sexual domains between groups. Conclusions: KTx recipients have significantly fewer urinary symptoms, pain, work-related disturbances, suspected UTIs, and hospitalizations associated with stent placement than urolithiasis patients.